Molecular Regulation of Ocular Gland Development

眼腺发育的分子调控

基本信息

  • 批准号:
    7659617
  • 负责人:
  • 金额:
    $ 34.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Dry eye syndrome affects millions of people worldwide and is one of the most common ocular diseases. Dry eye syndromes are relatively common among the aging population and in women. Though the pathogenesis of dry eye likely involves multiple components, lacrimal gland dysfunction and tear deficiencies are major components. The absence of tears, in severe cases, can lead to abrasion of the corneal surface and blindness. Though lacrimal gland physiology has been well studied, relatively very little is known about the regulatory mechanisms that shape lacrimal gland development. Our long-term goal is to define these regulatory mechanisms and to build a comprehensive model of glandular development. Acquisition of this knowledge will be critical for devising alternative treatment options for patients with lacrimal gland disorders such as dry eye syndromes. Our previous studies have shown that FGF-10, a member of the fibroblast growth factor (FGF) family, is both necessary and sufficient for initiation of differentiation of lacrimal and Harderian glands in the murine eye. These studies established FGF-10 as an important component of the signaling system that induces glandular growth and Differentiation. Mutations in FGF-10 in human patients have been shown to be the underlying cause for aplasia of the lacrimal and salivary glands (ALSG) syndrome, a condition characterized by irritable eyes and dryness of the mouth. These findings underscore the importance of FGF-10 signaling to human lacrimal gland development. The objective of this application is to build on our previous studies and define the roles of downstream components of the FGF-10 signaling pathway that are critical for glandular differentiation. We will focus our efforts on Ras, a downstream effector of FGF-10 signaling (Aim 1), Sprouty, a downstream target and antagonist of FGF-10 signaling (Aim 2), and Edar (ectodysplasin receptor), a downstream target of FGF-10 signaling (Aim 3). These studies will be performed by gain- and loss-of-function studies in mice. As the FGF-10 signaling pathway has been shown to be a critical regulator of branching and epithelial-mesenchymal interactions in multiple organ rudiments including the lungs and limbs, a clear understanding of the mechanistic details of the FGF-10 signaling pathway will have broad significance in the field of developmental biology. In addition, the proposed studies will, in the long-term, allow the development of novel therapeutic approaches for treatment of patients with dry eye syndromes.
描述:干眼症综合症会影响全球数百万的人,并且是最常见的眼部疾病之一。干眼综合征在老龄化人群和女性中相对普遍。尽管干眼症的发病机理可能涉及多种成分,但泪腺功能障碍和泪液缺陷是主要成分。在严重的情况下,没有泪水会导致角膜表面和失明。尽管对泪腺生理学进行了充分的研究,但对塑造泪腺发育的调节机制的了解相对较少。我们的长期目标是定义这些调节机制,并建立腺体发育的综合模型。获得这些知识的获取对于为泪腺疾病(如干眼综合征)的患者设计替代治疗方案至关重要。我们先前的研究表明,FGF-10是成纤维细胞生长因子(FGF)家族的成员,对于鼠眼中富集和硬腺腺体的分化是必要且足够的。这些研究将FGF-10确定为诱导腺体生长和分化的信号系统的重要组成部分。人类患者中FGF-10的突变已被证明是富富富集和唾液腺(ALSG)综合征的基本原因,这种疾病的特征是眼睛易怒和口腔干燥。这些发现强调了FGF-10信号传导对人泪腺发育的重要性。该应用的目的是建立我们以前的研究,并定义FGF-10信号通路的下游成分的作用,这对于腺体分化至关重要。我们将重点放在RAS上,RAS是FGF-10信号传导的下游效应器(AIM 1),Sproty,下游目标和FGF-10信号传导的对手(AIM 2)和Edar(Ectodysplasin受体),FGF-10信号的下游目标(AIM 3)。这些研究将通过小鼠的功能丧失研究进行。由于已显示FGF-10信号通路是包括肺部和四肢在内的多个器官方向存在的分支和上皮 - 间质相互作用的关键调节剂,因此对FGF-10信号传导途径的机械细节的清晰理解在发育生物学领域中具有广泛的意义。此外,拟议的研究将长期发展,允许开发新型的治疗方法来治疗干眼症患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VENKATESH GOVINDARAJAN其他文献

VENKATESH GOVINDARAJAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VENKATESH GOVINDARAJAN', 18)}}的其他基金

Regulation of parietal bone differentiation
顶骨分化的调节
  • 批准号:
    7237359
  • 财政年份:
    2006
  • 资助金额:
    $ 34.83万
  • 项目类别:
Regulation of parietal bone differentiation
顶骨分化的调节
  • 批准号:
    7072980
  • 财政年份:
    2006
  • 资助金额:
    $ 34.83万
  • 项目类别:
Molecular Regulation of Ocular Gland Development
眼腺发育的分子调控
  • 批准号:
    7279816
  • 财政年份:
    2006
  • 资助金额:
    $ 34.83万
  • 项目类别:
Molecular Regulation of Ocular Gland Development
眼腺发育的分子调控
  • 批准号:
    7494521
  • 财政年份:
    2006
  • 资助金额:
    $ 34.83万
  • 项目类别:
Molecular Regulation of Ocular Gland Development
眼腺发育的分子调控
  • 批准号:
    7131472
  • 财政年份:
    2006
  • 资助金额:
    $ 34.83万
  • 项目类别:
Molecular Regulation of Ocular Gland Development
眼腺发育的分子调控
  • 批准号:
    7903928
  • 财政年份:
    2006
  • 资助金额:
    $ 34.83万
  • 项目类别:

相似国自然基金

巨噬细胞极化在糖尿病视网膜纤维增生中的作用及其调节机制
  • 批准号:
    81760149
  • 批准年份:
    2017
  • 资助金额:
    34.0 万元
  • 项目类别:
    地区科学基金项目
盲人脑网络可塑性的磁共振影像研究
  • 批准号:
    30900476
  • 批准年份:
    2009
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of a novel depot delivery system for a glaucoma therapeutic
开发用于青光眼治疗的新型储库递送系统
  • 批准号:
    10699791
  • 财政年份:
    2023
  • 资助金额:
    $ 34.83万
  • 项目类别:
Cell Therapy Program with Scale-up cGMP Manufacturing of Human Corneal Stromal Stem Cells
细胞治疗计划,扩大人类角膜基质干细胞的 cGMP 生产
  • 批准号:
    10720562
  • 财政年份:
    2023
  • 资助金额:
    $ 34.83万
  • 项目类别:
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary
圆锥角膜、性激素和垂体前叶之间的密切相互作用
  • 批准号:
    10746247
  • 财政年份:
    2023
  • 资助金额:
    $ 34.83万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 34.83万
  • 项目类别:
Racial disparities of open angle glaucoma: A study of mitochondria and oxidative stress in human trabecular meshwork
开角型青光眼的种族差异:人类小梁网线粒体和氧化应激的研究
  • 批准号:
    10735655
  • 财政年份:
    2023
  • 资助金额:
    $ 34.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了